The present invention provides the ability to treat acne with a device that can be worn by a patient for extended time periods. The device can, for example, enable the delivery of light for time periods that are longer than one might want to sit still in front of a stationary light source. The device is a flexible container that may be fitted to parts of the body to be treated. An example of such a flexible container is a mask for the face. The mask covers the face and has a strap to hold it to the face. The mask is located relative to a light source generating light by chemiluminescence. The mask is worn for a period of time needed to provide the desired amount of light energy to the tissue.
|
1. A method of treating a skin condition of a patient comprising:
(a) generating, by chemiluminescence, light having a wavelength between about 400 nm and about 450 nm;
(b) using an illuminating mask, located relative to the light source, to expose at least a portion of skin of a patient to the light to treat the skin condition of the patient; and
(c) exposing the skin of the patient to at least one of a skin softener and a cleanser.
9. An apparatus for treating a skin condition of a patient comprising:
(a) a chemiluminescent light source generating light having a wavelength between about 400 nm and about 450 nm;
(b) a mask, located relative to the light source, the mask capable of exposing the light to a portion of skin of a patient, the mask having a front side and a back side; and
(c) a source of at least one of a skin softener and a cleanser connected to the back side, whereby the at least one of a skin softener and a cleanser can transfer to the skin of the patient.
2. The method of
(a-a) generating additional light having a wavelength between about 630 nm and about 690 nm.
3. The method of
4. The method of
5. The method of
6. The method of
7. The method of
(a-a) generating additional light having a wavelength between about 525 nm and about 575 nm.
11. The apparatus of
(b-a) a first portion containing a first chemical;
(b-b) a second portion containing a second chemical, the second chemical separated from the first chemical by a separating mechanism.
12. The apparatus of
13. The apparatus of
17. The apparatus of
18. The apparatus of
19. The apparatus of
20. The apparatus of
21. The apparatus of
22. The apparatus of
|
This application claims priority to U.S. provisional patent application Ser. No. 60/366,551, filed Mar. 25, 2002. The provisional application Ser. No. 60/366,551 is incorporated by reference herein.
The present invention provides for a method and apparatus for the application of specific wavelengths of light to skin tissue for the purpose of treating and healing acne lesions
Roughly 45 million people in the US are afflicted by the skin condition acne vulgaris. It is associated with lesions on the skin that are unsightly but can also be painful and leave scars.
The exact etiology of acne remains controversial. Keratinous material initially plugs the duct of a sebaceous gland. Sebum is produced and trapped, thereby enlarging the gland. The propionibacterium acnes (P. acnes) bacterium, which is a normal part of the skin flora, propagates in the gland due to the sebum buildup. These bacteria are inflammatory and may lead to the formation of the acne pustules.
Treatments typically include topical and systemic therapies. Topical treatments are aimed at removing follicular plugs and cleaning the sebaceous glands. These treatments are useful in treating some minor forms of acne. Oral treatments include antibiotics to suppress the growth of P. acnes. However, these treatments have side effects typical of these drugs, such as skin dryness, digestive problems, and the development of antibiotic resistant bacteria.
It is known that the P. acnes bacteria produce porphyrins. The particular porphyrin typically produced by P. acnes has a peak in absorption at 415 nanometers. Although red light is absorbed less, the light penetrates the skin deeper than other light. Thus, devices often include 660 nanometer light as well. Also, red light has an anti-inflammatory effect on tissue and may therefore aid in improving healing of pustules.
More recently, the use of both blue light (e.g., 415 nm) and red light (e.g., 660 nm) in the treatment of acne has been described. These lights can be applied with and without photo enhancers. These devices typically require high energy light sources to limit the treatment time to a period that is acceptable for a person to sit still. For example, the light sources tend to be high energy fluorescent bulbs and LEDs.
The present invention provides the ability to treat acne with a device that can be worn by a patient for extended time periods. The device can, for example, enable the delivery of light for time periods that are longer than one might want to sit still in front of a stationary light source. The device is a flexible container that may be fitted to parts of the body to be treated. An example of such a flexible container is a mask for the face. The mask covers the face and has a strap to hold it to the face. The mask is located relative to a light source generating light by chemiluminescence. The mask is worn for a period of time needed to provide the desired amount of light energy to the tissue.
Chemiluminescence is a chemical reaction that emits light. In practice, two chemicals in liquid form are mixed together. In one embodiment, the mask contains a first portion storing a first chemical and a second portion storing a second chemical. The chemicals mix when, for example, the user breaks a breakable barrier (i.e., a separating mechanism) separating the two portions. The resulting chemical reaction emits light of specific wavelength(s) and for certain amounts of time. The chemicals contain both a dye(s) that creates the specific wavelength(s) of light and an energy-releasing reaction species providing the energy required to “pump” the dye molecules to a higher energy state. When the dye molecule naturally relaxes from its higher energy state, a photon of a specific wavelength is released. The proper selection of the chemicals can provide light of a specific wavelength peak, or, by combining multiple chemicals with different dyes, light of multiple peaks can be delivered. In addition, the chemicals providing the energy-supplying reaction can be selected to be a rapid, very energetic reaction or a longer, slower and less energetic reaction. If one desires a low light intensity for a long time, the chemicals are selected for a slow reaction rate. Conversely, for high intensity, the chemicals for a fast reaction are used. The total number of photons delivered depends on the energy produced by the reaction, the efficiency of the reaction in exciting the dye to its higher energy state, and the efficiency in the excited dye molecules returning to their lower energy state. The brightness of the illumination and the duration of the light are dependent on first order chemical reaction kinetics. That is, heating up the chemicals makes the reaction rate faster, approximately twice as fast for a 10 degree centigrade increase in temperature.
In one embodiment, the light source generates light having a wavelength between about 400 nm and about 450 nm. The light source can also generate additional light having a wavelength between about 630 nm and about 690 nm. In yet another embodiment, the light source generates additional light having a wavelength between about 525 nm and 575 nm.
The masks are made to fit various parts of the body that are affected by acne including the face and/or the back. In one embodiment, the mask is made from a flexible material. For the face, eye, nose and mouth holes are provided. The distal part of each mask is opaque to ensure that most of the light is directed to the tissue.
Referring to
Referring again to
Alternatively, the mask 1 may be filled with one of the necessary components. A thin glass ampule or plastic package filled with the other solution may be inserted into the mask. The user then breaks the glass ampule or plastic package by squeezing. This releases the activator which mixes with the dye and activates the light source.
The activity of the chemicals is selected to provide blue light with a peak around 415 nm, as this is the wavelength of the peak kill rate of the P. acnes. In other embodiments, the light has a wavelength within a range of 400-450 nm. There is also a peak in the porphyrin absorption around 550 nm so that additionally, we may want to provide chemicals with outputs of 525-575 nm. In some embodiments, chemicals that provide red light around 660 nm (630-690 nm) are applied to reduce inflammation of the tissue. Any or all of these dyes might be included in each device.
The effectiveness of killing P. acnes is dependent on the total amount of energy delivered. In one embodiment, the total amount of energy exposure is between 320 and 430 J/cm2. Further, the energy delivered in these treatments can, for example, range from 4 to 90 mW/cm2. In other embodiments, longer treatments with lower energy exposures is more effective at killing the P. acnes bacteria. The benefit of this invention is that the user may wear the device and continue with daily chores or routines permitting the exposure of large amounts of energy per treatment at low powers or fluxes. Currently available light treatments require the user to sit or lie in front of a light source and therefore interrupts daily activity.
In addition to the light delivery, the mask can also deliver skin softeners or cleansers. The front sheet 7 is impregnated with skin cleansing solutions that transfers to the skin during the treatment.
In yet other embodiments, the mask 1 can be reused a predetermined number of times prior to disposal to, for instance, lower user costs. For example, the mask 1 may contain several compartments of activators, one of which is opened at a time. Another example is that the mask 1 has several glass ampules with activators inside the mask, and one glass ampule is broken at a time. The chemical reaction then proceeds until the activator is used up, but unreacted dye remains to react with the next activator that is exposed when the next glass ampule is broken.
The mask may also have a port through which the solutions can be introduced. Syringes are filled with each of the two solutions, dye and activator. Each component is then injected into the mask and mixed inside the mask. The port has a valve to keep the fluids inside during use. The valve is opened to drain the fluids after use prior to the next use.
Having described certain embodiments of the invention, it will now become apparent to one of skill in the art that other embodiments incorporating the concepts of the invention may be used. Therefore, the invention should not be limited to certain embodiments, but rather should be limited only by the spirit and scope of the following claims.
Levine, Andy, Tolkoff, Marc Joshua
Patent | Priority | Assignee | Title |
7841714, | Feb 07 2008 | QUANTUM MODULATION SCIENTIFIC INC | Retinal melatonin suppressor |
7984989, | Feb 07 2008 | Retinal melatonin suppressor comprising a filter layer | |
8882752, | Mar 03 2005 | EPIP LLC | Aesthetic treatment device |
D715454, | Jul 31 2013 | 360 THERAPEUTICS, INC | Cooling face mask |
Patent | Priority | Assignee | Title |
3984786, | May 28 1975 | Jersey Nuclear-Avco Isotopes, Inc. | Nozzle for free jet dye laser |
4814949, | Nov 13 1987 | CYALUME TECHNOLOGIES, INC | Chemiluminescent device |
4889129, | Sep 27 1982 | Health Research, Inc. | Apparatus for treatment of tumors |
4998930, | Aug 03 1988 | Phototherapeutic Systems | Intracavity laser phototherapy method |
5104392, | Mar 22 1985 | Massachusetts Institute of Technology | Laser spectro-optic imaging for diagnosis and treatment of diseased tissue |
5334171, | Jul 23 1991 | ARK CLO 2000-1, LIMITED | Flexible, noncollapsible catheter tube with hard and soft regions |
5399583, | Jan 20 1987 | The University of British Columbia | Method of treating skin diseases |
5405369, | Jan 25 1994 | Medical College of Ohio | Photochemical ablation of gastro-intestinal tissue for augmentation of an organ |
5445608, | Aug 16 1993 | PURDUE PHARMACEUTICAL PRODUCTS L P | Method and apparatus for providing light-activated therapy |
5531662, | Dec 17 1990 | Microwave Medical Systems, Inc. | Dual mode microwave/ionizing probe |
5653683, | Feb 28 1995 | B THERAPY LLC | Intracavitary catheter for use in therapeutic radiation procedures |
5671998, | Aug 30 1990 | Assembly device combining a container and a chemiluminescent light source | |
5800478, | Mar 07 1996 | PURDUE PHARMACEUTICAL PRODUCTS L P | Flexible microcircuits for internal light therapy |
5845640, | Sep 15 1997 | Spectra Science Corporation | Chemiluminescent sources for photodynamic therapy and photomedicine |
5871522, | Oct 28 1996 | Senasco, Inc.; SENASCO, INC | Apparatus and method for projecting germicidal ultraviolet radiation |
5876427, | Jan 29 1997 | PURDUE PHARMACEUTICAL PRODUCTS L P | Compact flexible circuit configuration |
5913883, | Aug 06 1996 | Therapeutic facial mask | |
5993378, | Oct 28 1980 | Electro-optical instruments and methods for treating disease | |
6183773, | Jan 04 1999 | GENERAL HOSPITAL CORPORATION, D B A MASSACHUSSETTS GENERAL HOSPITAL, THE | Targeting of sebaceous follicles as a treatment of sebaceous gland disorders |
6335465, | Sep 02 1997 | DUSA PHARMACEUTICALS, INC. | Sterilized 5-aminolevulinic acid |
6443978, | Apr 09 1999 | BioVentures, LLC | Photomatrix device |
6464625, | Jun 23 1999 | STERILIGHT, INC | Therapeutic method and apparatus for debilitating or killing microorganisms within the body |
6491618, | Jun 23 1999 | STERILIGHT, INC | Apparatus and method for debilitating or killing microorganisms within the body |
6685331, | Nov 12 1999 | Chemiluminescent device | |
JP10094583, | |||
RE35132, | Jan 13 1994 | CYALUME TECHNOLOGIES, INC | Solid, thin chemiluminescent device |
WO64537, | |||
WO9832370, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Mar 21 2003 | LumeRx, Inc. | (assignment on the face of the patent) | / | |||
Aug 05 2003 | TOLKOFF, MARC JOSHUA | Seedling Enterprises, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 014884 | /0430 | |
Aug 05 2003 | LEVINE, ANDY | Seedling Enterprises, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 014884 | /0430 | |
Jan 05 2004 | MARC JOSHUA TOLKOFF, SEEDLING ENTERPRISES, LLC | LUMERX, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 014909 | /0301 |
Date | Maintenance Fee Events |
Jan 13 2009 | REM: Maintenance Fee Reminder Mailed. |
Jul 05 2009 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Date | Maintenance Schedule |
Jul 05 2008 | 4 years fee payment window open |
Jan 05 2009 | 6 months grace period start (w surcharge) |
Jul 05 2009 | patent expiry (for year 4) |
Jul 05 2011 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jul 05 2012 | 8 years fee payment window open |
Jan 05 2013 | 6 months grace period start (w surcharge) |
Jul 05 2013 | patent expiry (for year 8) |
Jul 05 2015 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jul 05 2016 | 12 years fee payment window open |
Jan 05 2017 | 6 months grace period start (w surcharge) |
Jul 05 2017 | patent expiry (for year 12) |
Jul 05 2019 | 2 years to revive unintentionally abandoned end. (for year 12) |